Tesla's European EV registrations experienced a significant downturn in May, with notable declines reported in France (-67%), Sweden (-53.7%), Denmark (-30.5%), and Portugal (-68%), contrasting with a 213% surge in Norway; this follows a broader trend of underperformance in Europe, as April registrations fell 49% year-over-year, while overall EV registrations in the region increased. The disappointing sales figures come despite the release of the refreshed Model Y and coincide with reports of CEO Elon Musk's polarizing political activities and alleged drug use, potentially impacting brand perception and consumer demand.
Tesla (TSLA) stock declined approximately 2.5% following reports of significant sales challenges in Europe during May. New vehicle registration data revealed substantial year-over-year drops in key markets: France (-67% to 721 units), Sweden (-53.7% to 503 units), Denmark (-30.5%), Netherlands (-36%), Spain (-19%), and Portugal (-68%). This contrasts sharply with Norway, where Model Y sales surged 213% to 2,346 units in May, a market where EV penetration is nearly 94%. These declines are particularly concerning as they occurred despite the recent launch of a refreshed Model Y, which was anticipated to boost sales, although the cheapest rear-wheel-drive version is not yet available in all regions but is expected this month. The May figures extend a negative trend, with Tesla's European EV registrations having already fallen 49% year-over-year in April to 14,228 units, marking its fourth consecutive month of decline. This underperformance is stark when compared to the overall European EV market, which saw registrations rise 34.1% in April, with competitors like Volkswagen, BMW, and BYD reportedly gaining market share. The demand weakness is potentially exacerbated by brand image issues linked to CEO Elon Musk's political activities, including his association with the Department of Government Efficiency (DOGE) and support for President Trump, and recent, serious allegations reported by The New York Times regarding his alleged drug use. While Musk's departure from his role in Washington D.C. might offer some respite, the negative publicity surrounding his conduct poses an ongoing risk to consumer perception and demand.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly negative
Sentiment Score
-0.70
Ticker Sentiment